Positron emission tomography (PET) drugs, pipelines and market
Positron emission tomography (PET) is a nuclear medicine imaging technique that produces a three-dimensional image or picture of functional processes in the body. Drugs Used to Treat Positron Emission Tomography Imaging
Common isotopes used in PET drugs
drug name | generic name | diagnose | company | structure | year |
Amyvid | florbetapir F 18 | Alzheimer’s disease | Avid Radiopharmaceuticals/Eli Lilly | 2011 | |
NeuraCeq | Florbetaben (18F) | Alzheimer’s disease | LIFE MOLECULAR | 2014 | |
AMYViD | florbetapir F 18 | Alzheimer’s disease | Avid Radiopharmaceuticals/Eli Lilly | 2011 | |
Vizamyl | flutemetamol f-18 | Alzheimer’s disease | GE healthcare | 2014 | |
Tauvid | flortaucipir F 18 | Alzheimer’s disease | Avid Radiopharmaceuticals/Eli Lilly | 2020 | |
Cerianna | fluoroestradiol F18 | breast cancer | Zionexa USA | 2020 | |
Cardiogen-82 | Rubidium-82 chloride | heart disease | Bracco Diagnostics | 82RbCl | 1989 |
NETSPOT | gallium ga 68 dotatate | neuroendocrine tumors | Advanced Accelerator Applications USA, | 2016 | |
GALLIUM DOTATOC GA 68 | gallium ga-68 dotatoc | neuroendocrine tumors | UIHC | 2019 | |
Axumin | Fluciclovine (18F) | prostate cancer | Blue Earth Diagnostics, Ltd., United Kingdom | 2016 | |
choline c-11 | 2-hydroxyethyl-dimethyl-(111C)methylamonium | prostate cancer | Mayo Clinic | 2012 | |
Ruby-Fill | 82RbCl | regional myocardial perfusion | JUBILANT DRAXIMAGE | 82RbCl | 2016 |
Fludeoxyglucose F 18 | Fludeoxyglucose F 18 | assessment of glucose metabolism,imaging tumors,Alzheimer’s disease. | multiple | 1976 |